Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127439071 | 12743907 | 1 | I | 20160908 | 20160914 | 20160914 | EXP | US-ABBVIE-16P-163-1722488-00 | ABBVIE | SHARON N, CULLEN C, MARTINEZ K. A COMPLEX PRESENTATION OF PEDIATRIC NEUROLEPTIC MALIGNANT SYNDROME RELATED TO POLYPHARMACY IN A 12 YEAR OLD MALE. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2015;26(6):571-573. | 12.00 | YR | M | Y | 0.00000 | 20160914 | MD | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127439071 | 12743907 | 1 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 375 MG IN AM, 500 MG IN PM | Y | UNKNOWN | 18081 | BID | |||||||
| 127439071 | 12743907 | 2 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | Y | UNKNOWN | 18081 | |||||||||
| 127439071 | 12743907 | 3 | I | PAROXETINE. | PAROXETINE | 1 | Unknown | QAM | Y | UNKNOWN | 0 | 40 | MG | QD | |||||
| 127439071 | 12743907 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | Y | Y | UNKNOWN | 0 | .5 | MG | BID | |||||
| 127439071 | 12743907 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.5 MG QAM, 1 MG AT BEDTIME | Y | Y | UNKNOWN | 0 | BID | ||||||
| 127439071 | 12743907 | 6 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | Y | Y | UNKNOWN | 0 | .5 | MG | ||||||
| 127439071 | 12743907 | 7 | SS | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | Unknown | QAM | Y | UNKNOWN | 0 | 36 | MG | QD | |||||
| 127439071 | 12743907 | 8 | I | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | Unknown | AT BEDTIME | Y | UNKNOWN | 0 | .125 | MG | QD | |||||
| 127439071 | 12743907 | 9 | C | MELATONIN | MELATONIN | 1 | Unknown | AT BEDTIME | UNKNOWN | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127439071 | 12743907 | 1 | Complex partial seizures |
| 127439071 | 12743907 | 3 | Product used for unknown indication |
| 127439071 | 12743907 | 4 | Product used for unknown indication |
| 127439071 | 12743907 | 7 | Product used for unknown indication |
| 127439071 | 12743907 | 8 | Product used for unknown indication |
| 127439071 | 12743907 | 9 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127439071 | 12743907 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127439071 | 12743907 | Drug interaction | Drug interaction |
| 127439071 | 12743907 | Neuroleptic malignant syndrome | Neuroleptic malignant syndrome |
| 127439071 | 12743907 | Serotonin syndrome | Serotonin syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |